RedHill Biopharma (RDHL) Times Interest Earned (2012 - 2023)

RedHill Biopharma (RDHL) has 12 years of Times Interest Earned data on file, last reported at $27.91 in Q2 2023.

• Times Interest Earned for Q2 2023 came in at $27.91, up 1184.06% year-over-year; the trailing twelve-month figure through Jun 2023 was -$1.32 (up 78.89% YoY), and the FY2025 annual result was -$5.45, down 27.37% from the prior year.
• Times Interest Earned improved to $27.91 in Q2 2023 per RDHL's latest filing, from -$69.07 in the prior quarter.
• Over five years, Times Interest Earned peaked at $167.3 in Q2 2019 and troughed at -$69.07 in Q1 2023.
• A 5-year average of $15.0 and a median of $4.3 in 2020 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2019 and 2023: Times Interest Earned surged 2905.64% in 2019, then plunged 1719.57% in 2023.
• A 5-year view of Times Interest Earned shows it stood at $62.91 in 2019, then slumped by 93.12% to $4.33 in 2020, then slumped by 987.5% to -$38.41 in 2021, then rose by 20.52% to -$30.53 in 2022, then soared by 191.42% to $27.91 in 2023.
• Business Quant data shows RDHL's Times Interest Earned at $27.91 in Q2 2023, -$69.07 in Q1 2023, and -$30.53 in Q4 2022.